Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS)

International Angiology

Volumn 25, Issue 3, 2006, Pages 287-292

  Tsuchida, H ^a   Shigematsu, Hiroshi ^b   Ishimaru, S ^b   Iwai, T ^c   Akaba, N ^d   Umezu, S ^e  

^a Department of Cardiovascular Surgery   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d Jinyukai Maeda Hospital   (Japan)

^e TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

Author keywords

Apheresis, LDL; Fibrinogen; Lipoproteins, LDL; Near Infrared; Recovery Ability Index; Red cell filtration rate; Spectroscopy

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; APHERESIS; ARTERY DISEASE; ARTICLE; BLOOD RHEOLOGY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; INTERMITTENT CLAUDICATION; MALE; MICROCIRCULATION; MULTICENTER STUDY; MUSCLE ISCHEMIA; NEAR INFRARED SPECTROSCOPY; NON INVASIVE MEASUREMENT; STUDENT T TEST; SYMPTOMATOLOGY; TREADMILL ERGOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WALKING;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ERYTHROCYTES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HEMOSTASIS; HUMANS; HYPERCHOLESTEROLEMIA; INTERMITTENT CLAUDICATION; ISCHEMIA; JAPAN; LOWER EXTREMITY; MALE; MICROCIRCULATION; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLASMAPHERESIS; PLETHYSMOGRAPHY; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SPECTROSCOPY, NEAR-INFRARED; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 33749325071     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y et al., for LARS Investigators. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-loweing drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 1992;95:1-13.
2. Nishimura S, Sekiguchi M, Kano T, Ichikawa S, Nagasaki F, Nishide T et al. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS). Atherosclerosis 1999;144:409-17.
3. Matsuzaki M, Hiramori K, Imaizumi T, Kitabatake A, Hishida H, Nomura M et al. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia. J Am Coll Cardiol 2002;40:220-7.
4. Kroon AA, Aengevaeren WRM, van der Werf T, Uijen GJH, Reiber JHC, Bruschke AVG et al. LDL-apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93:1826-35.
5. Mabuchi H, Koizumi J, Shimizu M, Kajinami K, Miyamoto S, Ueda K et al. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Am J Cardiol 1998;82:1484-95.
6. Bauer TA, Brass EP, Hiatt WR. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg 2004;40:488-93.
7. Jarm T, Kragelj R, Liebert A, Lukasiewitz P, Erjavec T, Preseren-Strukelj M et al. Postoocclusive reactive hyperemia in healthy volunteers and patients with peripheral vascular disease measured by three noninvasive methods. Adv Exp Med Biol 2003;530:661-9.
8. Hosoi Y, Yasuhara H, Miyata T, Komiyama T, Onozuka A, Shigematsu H. Comparison of near-infrared spectroscopy with air plethysmography in detection of deep vein thrombosis. Int Angiol 1999;18:287-93.
9. Komiyama T, Shigematsu H, Yasuhara H, Muto T. An objective assessment of intermittent claudication by near-infrared spectroscopy. Eur J Vasc Surg 1994;8:294-6.
10. Ichiki M, Ouchi H. Non-invasive evaluation of calf claudication by near-infrared laser spectrophotometry. J Jpn Coll Angiol 1995;35:53-9.
11. Seiyama A, Hazeki O, Tamura M. Noninvasive quantitative analysis of blood oxygenation in rat skeletal muscle. J Biochem 1988;103:419-24.
12. Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL. A simple method for measuring erythrocyte deformability. J Clin Pathol 1976;29:855-8.
13. Ichihashi H, Tsuchida H, Takae H, Ishimaru S. Examination of intermittent claudication based on near-infrared spectroscopy. Jpn J Vasc 2001;10:583-9.
14. Agishi T, Kitano Y, Suzuki T, Miura A, Murakami J, Minagawa H et al. Improvement of peripheral circulation by low density lipoprotein adsorption. Trans Am Soc Artif Intern Organs 1989;35:349-51.
15. Rubba P, Innuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A et al. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation 1990;81:610-6.
16. Agishi T, Tanabe T, Nishimura A, Furukawa K, Miyamoto T, Ohishi K et al. LDL apheresis as a gteratment of arteriosclerosis obliterans in the lower extremities: a multicenter study (abstract). J Jpn Coll Angiol 1992;32:333-9.
17. Koenig W, Ditschuneit HHM, Hehr R, Grunewald RW, Ernst E, Hombach V. Blood rheology after LDL apheresis using dextran sulfate cellulose adsorption: a case report. Angiology 1992;43:606-9.
18. Naganuma S, Agishi T, Ota K. Hemorheological effects of low density lipoprotein apheresis on atherosclerosis disease with hyperlipidemia. In: Agishi T, Kawamura A, Mineshima M, editors. Therapeutic Plasmapheresis (XII). Proceedings of the 4th International Congress of the World Apheresis Association and the 12th Annual Symposium of the Japanese Society for Apheresis, June 1992, Sapporo, Japan.
19. Schechner V, Ben-Ami R, Hershcovici T, Yedgar S, Beigel Y, Shapira I et al. Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis: implications for rheological studies. Ther Apher Dial 2005;9:379-84.
20. Kojima S, Harada-Shiba M, Toyota Y, Kimura G, Tsushima M, Kuramochi M et al. Change in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. Int J Artif Organs 1992;15:185-90.
21. Kunisel W, Di Nicuolo A, Pfohl M, Muller H, Riscler T, Eggstein M et al. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Int Med 1993;234:479-87.
22. Smith FB, Lee AJ, Hau CM, Rumley A, Lowe GDO, Fowkes GR. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Blood Coagul Fibrinolysis 2000;11:43-50.
23. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82.
24. Ichiki M, Ouchi H, Sai K, Taeda Y. Low-density lipoprotein apheresis in the treatment of arteriosclerosis obliterans and correlation with bradykinin (abstract). Jpn J Vasc Surg 1995;4:601-6.
25. Kizaki Y, Ueki Y, Yoshida K, Yano M, Matsumoto K, Miyake S et al. Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease? Blood Coagul Fibrinolysis 1999;10:341-9.
26. Stamler JS, Jia Li, Eu JP, McMathon TJ, Demchenko IT, Bonaventura J et al. Blood flow regulation by S-nitroso-hemoglobin in the physiological oxygen gradient. Science 1997;276:2034-7.
27. Mii S, Mori A, Sakata H, Nakayama M, Tsuruta H. LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: Change in prostacyclin and effect on ischemic symptoms. Angiology 1998;49:175-80.
28. Uno H, Ueki Y, Murashima J, Miyake S, Tominaga Y, Eguchi K et al. Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterance. Atherosclerosis 1995;116:93-102.
29. Takagi M, Yamada T, Yamaguchi H, Hashiyada H, Narimatsu N, Shibata R et al. The role of low-density lipoprotein apheresis as postoperative care of bypass grafting for chronic arterial occlusion. Cardiovasc Surg 1996;4:459-65.
30. Kamimura M, Matsuo M, Miyahara T, Kimura K, Matsumoto K, Nakaya T et al. Improvement in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease. Ther Apher 2002;6:467-70.
31. Kroon AA, van Asten WNJC, Stalenhoef AFH. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Ann Intern Med 1996;125:945-54.
32. Kobayashi S, Moriya H, Negishi K, Maesato K, Ohtake T. LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb. J Clin Apheresis 2003;18:115-9.
33. Kojima S, Shida M, Tanaka K, Takano H, Yokoyama H, Kuramochi M. Acute changes in 32. plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis. Ther Apher 33. 2000;5:2-6.